These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 25028549)

  • 1. Preparation and characterization of Tamoxifen citrate loaded nanoparticles for breast cancer therapy.
    Maji R; Dey NS; Satapathy BS; Mukherjee B; Mondal S
    Int J Nanomedicine; 2014; 9():3107-18. PubMed ID: 25028549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of biodegradable polymer based tamoxifen citrate loaded nanoparticles and effect of some manufacturing process parameters on them: a physicochemical and in-vitro evaluation.
    Sahana B; Santra K; Basu S; Mukherjee B
    Int J Nanomedicine; 2010 Sep; 5():621-30. PubMed ID: 20856837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of poloxamer 188 on nanoparticle morphology, size, cancer cell uptake, and cytotoxicity.
    Yan F; Zhang C; Zheng Y; Mei L; Tang L; Song C; Sun H; Huang L
    Nanomedicine; 2010 Feb; 6(1):170-8. PubMed ID: 19447200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: effects of surfactants on particles size, characteristics and in vitro performance.
    Liu Y; Pan J; Feng SS
    Int J Pharm; 2010 Aug; 395(1-2):243-50. PubMed ID: 20472049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological evaluation of 5-fluorouracil nanoparticles for cancer chemotherapy and its dependence on the carrier, PLGA.
    Nair K L; Jagadeeshan S; Nair SA; Kumar GS
    Int J Nanomedicine; 2011; 6():1685-97. PubMed ID: 21980233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of bicalutamide-loaded PLGA nanoparticles: preparation, characterization and in-vitro evaluation for the treatment of prostate cancer.
    Ray S; Ghosh Ray S; Mandal S
    Artif Cells Nanomed Biotechnol; 2017 Aug; 45(5):944-954. PubMed ID: 27327352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poly(lactic-
    Kumar P; Singh AK; Raj V; Rai A; Keshari AK; Kumar D; Maity B; Prakash A; Maiti S; Saha S
    Int J Nanomedicine; 2018; 13():975-990. PubMed ID: 29497292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Practical preparation procedures for docetaxel-loaded nanoparticles using polylactic acid-co-glycolic acid.
    Keum CG; Noh YW; Baek JS; Lim JH; Hwang CJ; Na YG; Shin SC; Cho CW
    Int J Nanomedicine; 2011; 6():2225-34. PubMed ID: 22114486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of novel coumarin-triazole hybrids and first evaluation of the 4-phenyl substituted hybrid loaded PLGA nanoparticles delivery system to the anticancer activity.
    Arvas B; Ucar B; Acar T; Varli HS; Arvas MB; Aydogan F; Yolacan C
    Nanotechnology; 2024 May; 35(30):. PubMed ID: 38636487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation, characterization, and in vitro and in vivo investigation of chitosan-coated poly (d,l-lactide-co-glycolide) nanoparticles for intestinal delivery of exendin-4.
    Wang M; Zhang Y; Feng J; Gu T; Dong Q; Yang X; Sun Y; Wu Y; Chen Y; Kong W
    Int J Nanomedicine; 2013; 8():1141-54. PubMed ID: 23658482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poly(D, L-lactide-co-glycolide)/montmorillonite nanoparticles for improved oral delivery of exemestane.
    Li Z; Liu K; Sun P; Mei L; Hao T; Tian Y; Tang Z; Li L; Chen D
    J Microencapsul; 2013; 30(5):432-40. PubMed ID: 23517067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro evaluation of PLGA loaded hesperidin on colorectal cancer cell lines: an insight into nano delivery system.
    Yaghoubi N; Gholamzad A; Naji T; Gholamzad M
    BMC Biotechnol; 2024 Aug; 24(1):52. PubMed ID: 39095760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scale up, optimization and stability analysis of Curcumin C3 complex-loaded nanoparticles for cancer therapy.
    Ranjan AP; Mukerjee A; Helson L; Vishwanatha JK
    J Nanobiotechnology; 2012 Aug; 10():38. PubMed ID: 22937885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carboplatin loaded Surface modified PLGA nanoparticles: Optimization, characterization, and in vivo brain targeting studies.
    Jose S; Juna BC; Cinu TA; Jyoti H; Aleykutty NA
    Colloids Surf B Biointerfaces; 2016 Jun; 142():307-314. PubMed ID: 26970818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, characterization, and evaluation of paclitaxel loaded in six-arm star-shaped poly(lactic-co-glycolic acid).
    Chen Y; Yang Z; Liu C; Wang C; Zhao S; Yang J; Sun H; Zhang Z; Kong D; Song C
    Int J Nanomedicine; 2013; 8():4315-26. PubMed ID: 24235829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surface modification of PLGA nanoparticles by carbopol to enhance mucoadhesion and cell internalization.
    Surassmo S; Saengkrit N; Ruktanonchai UR; Suktham K; Woramongkolchai N; Wutikhun T; Puttipipatkhachorn S
    Colloids Surf B Biointerfaces; 2015 Jun; 130():229-36. PubMed ID: 25937384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular delivery of PEGylated PLGA nanoparticles.
    Pamujula S; Hazari S; Bolden G; Graves RA; Chinta DD; Dash S; Kishore V; Mandal TK
    J Pharm Pharmacol; 2012 Jan; 64(1):61-7. PubMed ID: 22150673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Docetaxel-loaded nanoparticles based on star-shaped mannitol-core PLGA-TPGS diblock copolymer for breast cancer therapy.
    Tao W; Zeng X; Liu T; Wang Z; Xiong Q; Ouyang C; Huang L; Mei L
    Acta Biomater; 2013 Nov; 9(11):8910-20. PubMed ID: 23816645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective anticancer activity of hydroxyapatite/chitosan-poly(d,l)-lactide-co-glycolide particles loaded with an androstane-based cancer inhibitor.
    Ignjatović NL; Penov-Gaši KM; Wu VM; Ajduković JJ; Kojić VV; Vasiljević-Radović D; Kuzmanović M; Uskoković V; Uskoković DP
    Colloids Surf B Biointerfaces; 2016 Dec; 148():629-639. PubMed ID: 27694053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PLGA nanoparticle formulation of RK-33: an RNA helicase inhibitor against DDX3.
    Bol GM; Khan R; Heerma van Voss MR; Tantravedi S; Korz D; Kato Y; Raman V
    Cancer Chemother Pharmacol; 2015 Oct; 76(4):821-7. PubMed ID: 26330329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.